Resolute Wealth Strategies’s Merck MRK Stock Holding History

Resolute Wealth Strategies’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$918K	Buy	7,143 +69	+1%	+$8.08K	0.36%	43
2026 Q1	$851K	Buy	7,074 +29	+0.4%	+$3.35K	0.37%	42
2025 Q4	$742K	Buy	7,045 +897	+15%	+$84.2K	0.33%	46
2025 Q3	$516K	Sell	6,148 -1,478	-19%	-$122K	0.24%	55
2025 Q2	$604K	Sell	7,626 -470	-6%	-$37.4K	0.32%	47
2025 Q1	$727K	Buy	8,096 +443	+6%	+$41.4K	0.41%	39
2024 Q4	$761K	Buy	7,653 +38	+0.5%	+$3.92K	0.39%	40
2024 Q3	$865K	Sell	7,615 -14	-0.2%	-$1.66K	0.45%	36
2024 Q2	$944K	Sell	7,629 -83	-1%	-$10.7K	0.54%	31
2024 Q1	$1.02M	Buy	7,712 +11	+0.1%	+$1.36K	0.62%	31
2023 Q4	$840K	Sell	7,701 -86	-1%	-$8.93K	0.57%	30
2023 Q3	$802K	Buy	7,787 +35	+0.5%	+$3.77K	0.6%	28
2023 Q2	$894K	Buy	7,752 +36	+0.5%	+$4.09K	0.69%	27
2023 Q1	$821K	Buy	+7,716	New	+$833K	0.7%	27

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Resolute Wealth Strategies's MRK Position: Q2 2026 in Review

Resolute Wealth Strategies increased its Merck (MRK) stake by 0.98% in Q2 2026, buying an estimated $8.08K and bringing the position to 7,143 shares worth $918K. The position accounts for 0.36% of the portfolio, ranked #43.

Resolute Wealth Strategies first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.02M in Q1 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Resolute Wealth Strategies held 7,143 shares of Merck worth $918K as of Q2 2026.
Resolute Wealth Strategies bought 69 Merck shares in Q2 2026, an estimated $8.08K.
Merck made up 0.36% of Resolute Wealth Strategies's portfolio in Q2 2026, its #43 holding.
Resolute Wealth Strategies first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
Resolute Wealth Strategies's Merck position peaked at $1.02M in Q1 2024.
3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Resolute Wealth Strategies's 13F filing for Q2 2026, filed 12 Aug 2026.